CN Stock MarketDetailed Quotes

603707 Nanjing King-Friend Biochemical Pharmaceutical

Watchlist
  • 11.92
  • +0.04+0.34%
Not Open Jul 29 15:00 CST
19.26BMarket Cap-55962P/E (TTM)

Nanjing King-Friend Biochemical Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nanjing King-Friend Biochemical Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

1.00B

-23.19%
EPS(YoY)

0.11

-45.00%
Analyst Rating

Strong Buy

Jul 29, 2024

Nanjing King-Friend Biochemical Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.688B--
--2024/FY-- / 4.377B--
--2023/FY3.931B / 4.223B--
--2022/FY3.713B / 3.879B--
--2021/FY3.687B / 3.902B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.688B--
--2024/FY-- / 4.377B--
--2023/FY3.931B / 4.223B--
--2022/FY3.713B / 3.879B--
--2021/FY3.687B / 3.902B--

Unlock Free Earnings Estimates

Nanjing King-Friend Biochemical Pharmaceutical Earnings Reports

  • Jianyou Co., Ltd. 2024 First Quarter Report

    Apr 26 12:00 ET

  • Summary of the 2023 Annual Report of Jianyou Co., Ltd.

    Apr 26 12:00 ET

  • Jianyou Co., Ltd. 2023 Annual Report

    Apr 26 12:00 ET

  • Jianyou Co., Ltd. 2023 Annual Results Pre-Loss Announcement

    Jan 12 11:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 29, 2024

    Strong Buy

    • Strong Buy

      88.89%

    • Buy

      11.11%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg